Literature DB >> 21376172

Chemokine control of West Nile virus infection.

Jean K Lim1, Philip M Murphy.   

Abstract

West Nile virus (WNV) is a re-emerging pathogen responsible for fatal outbreaks of meningoencephalitis in humans. Recent research using a mouse model of infection has indicated that specific chemokines and chemokine receptors help mediate the host response to WNV acting by at least three mechanisms: control of early neutrophil recruitment to the infection site (Cxcr2), control of monocytosis in blood (Ccr2) and control of leukocyte movement from blood to brain (Cxcr4, Cxcr3, Cxcl10 and possibly Ccr5). CCR5 also appears to be important in human infection, since individuals genetically deficient in this receptor have increased risk of symptomatic disease once infected. These findings provide detailed insight into non-redundant chemokine roles in organ-specific leukocyte recruitment during infection, and emphasize the importance of the balance between pathogen control and immunopathology in determining overall clinical outcome. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376172      PMCID: PMC3050559          DOI: 10.1016/j.yexcr.2011.01.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  23 in total

Review 1.  CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection.

Authors:  Jean K Lim; William G Glass; David H McDermott; Philip M Murphy
Journal:  Trends Immunol       Date:  2006-06-05       Impact factor: 16.687

2.  Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis.

Authors:  W Peters; H M Scott; H F Chambers; J L Flynn; I F Charo; J D Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission.

Authors:  Jean K Lim; David H McDermott; Andrea Lisco; Gregory A Foster; David Krysztof; Dean Follmann; Susan L Stramer; Philip M Murphy
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

4.  Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression.

Authors:  Holly M Scott; JoAnne L Flynn
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 5.  West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States.

Authors:  Edward B Hayes; Duane J Gubler
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

Review 6.  Leukocyte recruitment during pulmonary Cryptococcus neoformans infection.

Authors:  G B Huffnagle; T R Traynor; R A McDonald; M A Olszewski; D M Lindell; A C Herring; G B Toews
Journal:  Immunopharmacology       Date:  2000-07-25

7.  West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice.

Authors:  D Ben-Nathan; I Huitinga; S Lustig; N van Rooijen; D Kobiler
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 8.  The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature.

Authors:  Todd W Kelley; Richard A Prayson; Angela I Ruiz; Carlos M Isada; Steven M Gordon
Journal:  Am J Clin Pathol       Date:  2003-05       Impact factor: 2.493

9.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

10.  Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis.

Authors:  Daniel R Getts; Rachael L Terry; Meghann Teague Getts; Marcus Müller; Sabita Rana; Bimmi Shrestha; Jane Radford; Nico Van Rooijen; Iain L Campbell; Nicholas J C King
Journal:  J Exp Med       Date:  2008-09-08       Impact factor: 14.307

View more
  30 in total

Review 1.  Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Authors:  Catalina Méndez; Chantelle L Ahlenstiel; Anthony D Kelleher
Journal:  World J Virol       Date:  2015-08-12

2.  West nile virus.

Authors:  Georg Pauli; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-07-04       Impact factor: 3.747

3.  Immune markers associated with host susceptibility to infection with West Nile virus.

Authors:  Feng Qian; Juilee Thakar; Xiaoling Yuan; Melissa Nolan; Kristy O Murray; William T Lee; Susan J Wong; Hailong Meng; Erol Fikrig; Steven H Kleinstein; Ruth R Montgomery
Journal:  Viral Immunol       Date:  2014-03       Impact factor: 2.257

Review 4.  CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV.

Authors:  Michelle B Kim; Kyle E Giesler; Yesim A Tahirovic; Valarie M Truax; Dennis C Liotta; Lawrence J Wilson
Journal:  Expert Opin Investig Drugs       Date:  2016-12       Impact factor: 6.206

5.  The Brave New World of Gene Editing and Molecular Medicine.

Authors:  Joel C Eissenberg
Journal:  Mo Med       Date:  2019 Nov-Dec

6.  Ending the Human Immunodeficiency Virus Pandemic: Optimizing the Prevention and Treatment Toolkits.

Authors:  Robert W Eisinger; Gregory K Folkers; Anthony S Fauci
Journal:  Clin Infect Dis       Date:  2019-11-27       Impact factor: 9.079

7.  SARM regulates CCL5 production in macrophages by promoting the recruitment of transcription factors and RNA polymerase II to the Ccl5 promoter.

Authors:  Claudia Gürtler; Michael Carty; Jay Kearney; Stefan A Schattgen; Aihao Ding; Katherine A Fitzgerald; Andrew G Bowie
Journal:  J Immunol       Date:  2014-04-07       Impact factor: 5.422

Review 8.  Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy.

Authors:  Eirini P Papapetrou; Axel Schambach
Journal:  Mol Ther       Date:  2016-02-12       Impact factor: 11.454

9.  CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells.

Authors:  Heather D Hickman; Glennys V Reynoso; Barbara F Ngudiankama; Stephanie S Cush; James Gibbs; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

10.  Dual Function of Ccr5 during Langat Virus Encephalitis: Reduction in Neutrophil-Mediated Central Nervous System Inflammation and Increase in T Cell-Mediated Viral Clearance.

Authors:  Daniela Michlmayr; Susana V Bardina; Carlos A Rodriguez; Alexander G Pletnev; Jean K Lim
Journal:  J Immunol       Date:  2016-04-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.